Garcia-Pena, A.; Ibarrola, J.; Navarro, A.; Sadaba, A.; Tiraplegui, C.; Garaikoetxea, M.; Arrieta, V.; Matilla, L.; Fernández-Celis, A.; Sadaba, R.;
et al. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. Int. J. Mol. Sci. 2021, 22, 2310.
https://doi.org/10.3390/ijms22052310
AMA Style
Garcia-Pena A, Ibarrola J, Navarro A, Sadaba A, Tiraplegui C, Garaikoetxea M, Arrieta V, Matilla L, Fernández-Celis A, Sadaba R,
et al. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. International Journal of Molecular Sciences. 2021; 22(5):2310.
https://doi.org/10.3390/ijms22052310
Chicago/Turabian Style
Garcia-Pena, Amaia, Jaime Ibarrola, Adela Navarro, Alba Sadaba, Carolina Tiraplegui, Mattie Garaikoetxea, Vanessa Arrieta, Lara Matilla, Amaya Fernández-Celis, Rafael Sadaba,
and et al. 2021. "Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease" International Journal of Molecular Sciences 22, no. 5: 2310.
https://doi.org/10.3390/ijms22052310
APA Style
Garcia-Pena, A., Ibarrola, J., Navarro, A., Sadaba, A., Tiraplegui, C., Garaikoetxea, M., Arrieta, V., Matilla, L., Fernández-Celis, A., Sadaba, R., Alvarez, V., Gainza, A., Jover, E., & López-Andrés, N.
(2021). Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. International Journal of Molecular Sciences, 22(5), 2310.
https://doi.org/10.3390/ijms22052310
